Did Novo Nordisk Executive Faint in Oval Office? Company Clarifies Amid Buzz About Gordon Findlay
A White House press conference on Thursday was briefly interrupted when a man fainted in the Oval Office. At that moment, President Donald Trump was unveiling a new agreement with pharmaceutical companies focused on reducing the cost of obesity medications.
The incident quickly spread online after a video of the collapse went viral. Independent journalist Eric Daugherty shared the footage and commented,
“A man just passed out during President Trump’s Oval Office announcement. Oz SPRUNG into action and assisted him.”
He later added a brief message:
“Pray for him.”
Social media users echoed his concern, posting messages of support for the unidentified man after the live feed was abruptly cut.
Speculation About Gordon Findlay
Initial online posts identified the individual as Gordon Findlay, an alleged Novo Nordisk executive. One viral post claimed:
“BREAKING: Novo Nordisk executive Gordon Findlay collapses during Trump's announcement in Oval Office, announcement suspended.”
However, these reports were quickly disputed.
Novo Nordisk Issues Clarification
In a statement to Newsweek, Novo Nordisk denied that the collapsed individual was affiliated with the company. The statement read:
“CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office. We hope the gentleman who suffered a medical incident today is okay.”
White House Comments
White House Press Secretary Karoline Leavitt also addressed the situation, explaining what took place during the event:
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted.”
Author’s Summary
An unidentified pharmaceutical representative fainted during President Trump’s Oval Office press conference, prompting online speculation later refuted by Novo Nordisk.